Limitations of our study included the identification of variants that were likely somatic in our analyses of hematologic cancers due to an expansion of hematopoietic clonal populations with the same acquired mutation (i.e., CHIP). This evidence concerns the gene STUB1 and hematopoietic and lymphoid cell neoplasm.